Byoung Chul Lee

Company: Kanaph Therapeutics

Job title: Chief Executive Officer

Seminars:

9:30am Key Success Factors for Bispecific ADCs; Target & Format Selection 9:30 am

Lessons from past ADC development, including: The importance of PK above TMDD (targetmediated drug deposition), payload with safety margin, and understanding of off-target toxicity Bi-specific target selection criteria: mechanistic synergy vs. target patient coverage Bi-specific format selection criteria: 2+2 vs. 1+1Read more

day: Bispecific ADC Seminar Day